Skip to main content
. 2025 Apr 12;19:2845–2862. doi: 10.2147/DDDT.S494915

Table 3.

The Role of Astragalus in Alleviating Liver and Lung Injury

Disease Administration and Dose Experimental Models Efficacy Mechanism Reference
Drug-induced liver injury Mongolian astragalus polysaccharide 100 mg/kg for 14 d Drug-induced liver injury induced by overdose of APAP intraperitoneal injection Mongolian Astragalus polysaccharides can alleviate APAP-induced drug-induced liver injury Nrf-2 and LC3Nrf-2, Keap-1 and their downstream target genes↑
MAPK, TNF-α, IL-6 and IL-1β↓
[37]
Liver damage Astragalus injection 2 g/mL for 7 d Adult healthy male Wistar rats Relieves hepatocyte apoptosis and has a hepatoprotective effect Bcl-2, Bcl-2/Bax↑ [85]
Liver damage AS-IV 20 and 40 mg/kg for 1 week ICR clean-grade mice treated with AS-IV AS-IV can significantly reduce the expression of inflammatory factors in mice with paracetamol-induced liver injury, and can play a certain therapeutic role in liver injury TNF-α, IL-1β, IL-6↓ [86]
Liver damage AS-IV 80 mg/kg for 8 weeks With AS-IV 80 mg/kg) and Metformin, Met; 120 mg/kg) separately treated in T2DMSD rats AS-IV has a certain protective effect on liver injury in T2DM Liver index, serum HOMA-IR, serum TNF-α, IL-6 levels↓
AMPK/mTOR pathway↑
[87]
Oxidative damage to hepatic stellate cells 100 and 200 μmol/L AS-IV for 36 h Hepatic stellate cells Astragaloside pretreatment attenuates oxidative damage to rat hepatic stellate cells Cell viability↑
Apoptotic cells, intracellular Caspase-3 and Caspase-9 expression levels, ROS levels↓
[88]
Acute liver injury Astragalus extract 350 mg/kg for 12 h Normal mice were treated with Astragalus extract and modeled 3 days after prophylactic administration of Astragalus extract Astragalus extract has anti-APAP acute liver injury effects Apoptosis-related genes MAPK14, CAT, ALT, AST↓ [89]
Liver fibrosis and liver injury Astragalus wt> 99.5%)
Compound soft-shelled turtle soft liver tablets, 9 weeks
Healthy mice were injected subcutaneously with corn oil solution containing 20% CCl4 at a dose of 6 mL/kg twice a week to establish a rat model of liver fibrosis injury Astragalus has an effective protective effect on liver injury in experimental liver fibrosis rats through the p38MAPK signaling pathway The expression of ALT, AST and TBIL, p38MAPK, MKK3 and ATF-2 proteins in serum↓ [90]